|
Volumn 312, Issue 3, 2014, Pages 294-295
|
Guidelines for managing high blood pressure
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ANTIHYPERTENSIVE AGENT;
AGE;
DRUG SAFETY;
FETUS DISEASE;
GENETIC HETEROGENEITY;
HIGH RISK PREGNANCY;
HORMONE DETERMINATION;
HUMAN;
HYPERTENSION;
LETTER;
METABOLISM;
OUTCOME ASSESSMENT;
PATHOPHYSIOLOGY;
PHARMACODYNAMICS;
PRACTICE GUIDELINE;
PRENATAL EXPOSURE;
PRIORITY JOURNAL;
RACE;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RISK ASSESSMENT;
SEX DIFFERENCE;
TERATOGENICITY;
NOTE;
ANTIHYPERTENSIVE AGENTS;
HUMANS;
HYPERTENSION;
|
EID: 84904258333
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.6593 Document Type: Letter |
Times cited : (4)
|
References (5)
|